127 related articles for article (PubMed ID: 3348836)
21. [Inhibitory effects of calcium channel antagonist on the proliferation of vascular smooth muscle cells induced by adrenoceptor activators].
Li Y; Wang R; Lin SX; Jia B; Song KM
Sheng Li Xue Bao; 1995 Jun; 47(3):269-74. PubMed ID: 7570113
[TBL] [Abstract][Full Text] [Related]
22. Effects of the calcium channel facilitator, CGP 28,392, on different modes of contraction in smooth muscle of rabbit and rat aortae and guinea-pig taenia caeci.
Karaki H; Nagase H; Ozaki H; Urakawa N; Weiss GB
Br J Pharmacol; 1986 Oct; 89(2):423-9. PubMed ID: 3779218
[TBL] [Abstract][Full Text] [Related]
23. Action of dihydropyridine calcium antagonists on early growth response gene expression and cell growth in vascular smooth muscle cells.
Ko Y; Totzke G; Graack GH; Heidgen FJ; Meyer zu Brickwedde MK; Düsing R; Vetter H; Sachinidis A
J Hypertens; 1993 Nov; 11(11):1171-8. PubMed ID: 8301097
[TBL] [Abstract][Full Text] [Related]
24. Suppression of rat carotid lesion development by the calcium channel blocker PN 200-110.
Handley DA; Van Valen RG; Melden MK; Saunders RN
Am J Pathol; 1986 Jul; 124(1):88-93. PubMed ID: 2942038
[TBL] [Abstract][Full Text] [Related]
25. [Effects of calcium antagonists on intracellular calcium deposits].
Raddino R; Poli E; Pelà G; Ferrari A; Ghirarduzzi A; Ferrari R
Cardiologia; 1987 Apr; 32(4):395-9. PubMed ID: 3113731
[No Abstract] [Full Text] [Related]
26. Apoptosis of vascular smooth muscle cells induced by cholesterol and its oxides in vitro and in vivo.
Yin J; Chaufour X; McLachlan C; McGuire M; White G; King N; Hambly B
Atherosclerosis; 2000 Feb; 148(2):365-74. PubMed ID: 10657573
[TBL] [Abstract][Full Text] [Related]
27. The effects of bepridil compared with calcium antagonists on rat and rabbit aorta.
Winslow E; Farmer S; Martorana M; Marshall RJ
Eur J Pharmacol; 1986 Nov; 131(2-3):219-28. PubMed ID: 3493158
[TBL] [Abstract][Full Text] [Related]
28. Effect of SR 33805 on arterial smooth muscle cell proliferation and neointima formation following vascular injury.
Dol F; Schaeffer P; Lamarche I; Mares AM; Chatelain P; Herbert JM
Eur J Pharmacol; 1995 Jul; 280(2):135-42. PubMed ID: 7589177
[TBL] [Abstract][Full Text] [Related]
29. Calcium antagonists suppress atherogenesis in aorta but not in the intramural coronary arteries of cholesterol-fed rabbits.
Ginsburg R; Davis K; Bristow MR; McKennett K; Kodsi SR; Billingham ME; Schroeder JS
Lab Invest; 1983 Aug; 49(2):154-8. PubMed ID: 6876744
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factor binding protein-1 inhibits arterial smooth muscle cell proliferation in vitro but does not reduce the neointimal response to balloon catheter injury.
Motani A; Rutherford C; Anggard EE; Ferns GA
Atherosclerosis; 1995 Nov; 118(1):57-66. PubMed ID: 8579632
[TBL] [Abstract][Full Text] [Related]
31. Effects of calcium entry blockers on contractions evoked by endothelin-1, [Ala3,11]endothelin-1 and [Ala1,15]endothelin-1 in rat isolated aorta.
Topouzis S; Pelton JT; Miller RC
Br J Pharmacol; 1989 Oct; 98(2):669-77. PubMed ID: 2684314
[TBL] [Abstract][Full Text] [Related]
32. Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery.
Chang MW; Ohno T; Gordon D; Lu MM; Nabel GJ; Nabel EG; Leiden JM
Mol Med; 1995 Jan; 1(2):172-81. PubMed ID: 8529096
[TBL] [Abstract][Full Text] [Related]
33. Calcium antagonists and vascular smooth muscle cells in atherogenesis.
Pauletto P; Sartore S; Giuriato L; Scatena M; Tonello M; Scannapieco G; Pessina AC; Dal Palù C
J Cardiovasc Pharmacol; 1992; 19 Suppl 2():S8-16. PubMed ID: 1377310
[TBL] [Abstract][Full Text] [Related]
34. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816
[TBL] [Abstract][Full Text] [Related]
35. Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations.
Fleckenstein-Grün G; Thimm F; Czirfuzs A; Matyas S; Frey M
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S75-84. PubMed ID: 7898099
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of calcium antagonists and Bay K 8644 on contractile responses to exogenous noradrenaline and adrenergic nerve stimulation in the rabbit ear artery.
Skärby TV; Högestätt ED
Br J Pharmacol; 1990 Dec; 101(4):961-7. PubMed ID: 1707708
[TBL] [Abstract][Full Text] [Related]
37. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth.
Igarashi M; Takeda Y; Mori S; Ishibashi N; Komatsu E; Takahashi K; Fuse T; Yamamura M; Kubo K; Sugiyama Y; Saito Y
Br J Pharmacol; 1997 Mar; 120(6):1172-8. PubMed ID: 9134232
[TBL] [Abstract][Full Text] [Related]
38. Vitamin E inhibits the intimal response to balloon catheter injury in the carotid artery of the cholesterol-fed rat.
Konneh MK; Rutherford C; Li SR; Anggård EE; Ferns GA
Atherosclerosis; 1995 Feb; 113(1):29-39. PubMed ID: 7755653
[TBL] [Abstract][Full Text] [Related]
39. Factors controlling growth of arterial cells following injury.
Reidy MA; Jackson CL
Toxicol Pathol; 1990; 18(4 Pt 1):547-53. PubMed ID: 2091233
[TBL] [Abstract][Full Text] [Related]
40. Atherosclerosis, calcium, and calcium antagonists.
Henry PD
Circulation; 1985 Sep; 72(3):456-9. PubMed ID: 3893790
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
